This interactive two day course will provide an overview of the current European pharmaceutical regulatory environment, procedures and obligations and discuss how to interpret and apply the ...
Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA CAMBRIDGE, Mass., Jan. 2 ...
New hire set to drive clinical development and U.S. commercialization of the continuous blood glucose monitor for people with diabetesRUTHE ...
Prototype medical devices allow designers and engineers to explore the practical aspects of their concepts, identify potential challenges, and refine functionalities before full-scale production.
The regulatory basis and compliance examples from FDA observations and warning letters are included to support the need for an effective process. The Center for Drug Evaluation and Research’s new ...
These rules are built in accordance the information provided in the following documents: Guidance Document - Preparation of Drug Regulatory Activities in Electronic Common Technical Document (eCTD) ...
Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...
Meta’s president of global affairs, former U.K. deputy prime minister Nick Clegg, is leaving the social giant after more than six years. Taking his place: Joel Kaplan, a Meta lobbying exec with ...
Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry and pharmacology. Targeted ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
keeping hold of its first place position at the top of the Mass Market Fiction chart. In total this week, volume sales have dropped 45.3% to 4.8 million, delivering sales of £48.1m, a decline of 46%.